Search Results 141-150 of 17574 for colitis

  1. A Study To Assess The Change In Disease Activity In Adult Participants With Moderate To Severe Ulcerative Colitis Treated With Risankizumab Compared To Vedolizumab - Mayo Clinic

    Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).

  2. Sharing Mayo Clinic: Lifting the weight of debilitating inflammatory bowel disease

    Ulcerative colitis and Crohn's disease are the two main types. Marissa began experiencing symptoms of inflammatory bowel disease when she was in her early ...

  3. A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

    Ozanimod will be administered orally to pediatric participants with moderate to severe active Ulcerative Colitis who have had an inadequate response to ...

  4. Low-fiber diet do's and don'ts - Mayo Clinic

    This may be due to a tumor or an inflammatory disease, such as Crohn's disease and ulcerative colitis. You have had bowel surgery. You are having treatment ...

  5. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    This study is designed to evaluate the efficacy and safety of tofacitinib (CP-690,550) in patients with moderate to severe ulcerative colitis who have failed or ...

  6. A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) - Mayo Clinic

    A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) ... Colitis (UC) or Crohn's disease (CD).

  7. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis · Overview.

  8. Mirikizumab-mrkz (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Mirikizumab-mrkz injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your ...

  9. Doctors and departments - Mayo Clinic

    ... colitis. Publications. See a list of publications about pouchitis by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine. By Mayo ...

  10. Christina Y. Ha, M.D. - Doctors and Medical Staff - Mayo Clinic

    The goals of the inflammatory bowel disease care team are: To provide expertise in management of Crohn's disease and ulcerative colitis. To utilize multi- ...